(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 11.11% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.21%.
Atricure's revenue in 2025 is $499,946,000.On average, 11 Wall Street analysts forecast ATRC's revenue for 2025 to be $26,901,387,883, with the lowest ATRC revenue forecast at $25,814,914,951, and the highest ATRC revenue forecast at $27,761,222,362. On average, 11 Wall Street analysts forecast ATRC's revenue for 2026 to be $30,227,903,589, with the lowest ATRC revenue forecast at $28,532,588,323, and the highest ATRC revenue forecast at $31,686,640,119.
In 2027, ATRC is forecast to generate $34,211,969,015 in revenue, with the lowest revenue forecast at $31,961,985,958 and the highest revenue forecast at $35,761,659,135.